相关实验视频
Updated: Jun 19, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
396
共同疾病和癌症护理编年史
Lucy H Pickett1, Janelle Tipton2
1Indiana University Health Arnett Hospital.
Clinical journal of oncology nursing
|July 23, 2024
概括
本研究探讨了复杂并发症的癌症患者的风险评估工具. 这些工具可以改善护理评估,并在具有挑战性的患者病例中预测不良结果.
科学领域:
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
- 临床流行病学临床流行病学
背景情况:
- 管理多种复杂并发症的癌症患者存在重大临床挑战.
- 准确评估患者的风险对于优化治疗和结果至关重要.
- 现有的风险分层方法可能无法完全捕捉这个群体中的复杂性.
研究的目的:
- 评估癌症和并发复杂并发症患者风险评估工具的有用性.
- 确定这些工具是否可以增强临床护理评估和预测不良结果.
主要方法:
- 审查现有的风险评估工具,适用于瘤患者.
- 对研究的分析,重点关注并发症负担及其对癌症治疗结果的影响.
- 综合关于风险评估工具在这个特定患者群体中的预测价值的证据.
主要成果:
- 风险评估工具显示出在识别具有高并发症负担的癌症患者方面的潜力.
- 这些工具可以帮助临床医生定制治疗计划和支持性护理.
- 目前正在研究工具对死亡率和治疗毒性等不良结果的预测准确性.
结论:
- 风险评估工具对于改善复杂癌症患者的护理非常有价值.
- 需要进一步的研究来验证和完善这些工具,以便更广泛的临床应用.
- 改进的风险评估可以带来更好的患者结果和资源配置.
相关概念视频
Methods of Documentation VI: Case Management Model
565
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
565
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336
Chronic Pancreatitis II: Collaborative Care
79
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
79
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K

